Search research articles
Contact Us
Filters
Showing results (441-450 of 592) with videos related to
Page
of 60
Sort By:
The International Journal of Biochemistry & Cell Biology
|
November 22, 2021
SSX2 promotes the formation of a novel type of intranuclear lamin bodies
S Traynor, N D Jakobsen, M F Ebbesen, et al.
Bone Marrow Transplantation
|
July 19, 2016
YKL-40 in allogeneic hematopoietic cell transplantation after AML and myelodysplastic syndrome
B Kornblit, T Wang, S J Lee, et al.
Plos One
|
February 6, 2014
Plasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: RESULTS from the NORDIC VII Study
Line S Tarpgaard, Tormod K Guren, Bengt Glimelius, et al.
Cancer Cell International
|
April 25, 2024
Human P2X7 receptor variants Gly150Arg and Arg276His polymorphisms have differential effects on risk association and cellular functions in pancreatic cancer
Lara Magni, Haoran Yu, Nynne M Christensen, et al.
Oncotarget
|
October 15, 2016
Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer
Maria Thomsen, Christian Kersten, Halfdan Sorbye, et al.
Journal of Clinical Immunology
|
September 28, 2023
Missed Opportunities to Diagnose Common Variable Immunodeficiency: a Population-Based Case-Control Study Identifying Indicator Diseases for Common Variable Immunodeficiency
Christina Dahl, Inge Petersen, Frederik V Ilkjær, et al.
BMC Cancer
|
January 13, 2009
YKL-40 tissue expression and plasma levels in patients with ovarian cancer
Estrid V S Høgdall, Merete Ringsholt, Claus K Høgdall, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 9, 2017
Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status
Maria Thomsen, Marianne Grønlie Guren, Eva Skovlund, et al.
British Journal of Cancer
|
June 7, 2018
Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome
Maria Thomsen, Eva Skovlund, Halfdan Sorbye, et al.
Journal of the American Heart Association
|
March 3, 2020
Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease
Jakob Schroder, Janus Christian Jakobsen, Per Winkel, et al.
Page
of 60
Search research articles
Search
Showing results (441-450 of 592) with videos related to
Sort By:
Page
of 60
The International Journal of Biochemistry & Cell Biology
|
November 22, 2021
SSX2 promotes the formation of a novel type of intranuclear lamin bodies
S Traynor, N D Jakobsen, M F Ebbesen, et al.
Bone Marrow Transplantation
|
July 19, 2016
YKL-40 in allogeneic hematopoietic cell transplantation after AML and myelodysplastic syndrome
B Kornblit, T Wang, S J Lee, et al.
Plos One
|
February 6, 2014
Plasma YKL-40 in patients with metastatic colorectal cancer treated with first line oxaliplatin-based regimen with or without cetuximab: RESULTS from the NORDIC VII Study
Line S Tarpgaard, Tormod K Guren, Bengt Glimelius, et al.
Cancer Cell International
|
April 25, 2024
Human P2X7 receptor variants Gly150Arg and Arg276His polymorphisms have differential effects on risk association and cellular functions in pancreatic cancer
Lara Magni, Haoran Yu, Nynne M Christensen, et al.
Oncotarget
|
October 15, 2016
Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer
Maria Thomsen, Christian Kersten, Halfdan Sorbye, et al.
Journal of Clinical Immunology
|
September 28, 2023
Missed Opportunities to Diagnose Common Variable Immunodeficiency: a Population-Based Case-Control Study Identifying Indicator Diseases for Common Variable Immunodeficiency
Christina Dahl, Inge Petersen, Frederik V Ilkjær, et al.
BMC Cancer
|
January 13, 2009
YKL-40 tissue expression and plasma levels in patients with ovarian cancer
Estrid V S Høgdall, Merete Ringsholt, Claus K Høgdall, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 9, 2017
Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status
Maria Thomsen, Marianne Grønlie Guren, Eva Skovlund, et al.
British Journal of Cancer
|
June 7, 2018
Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome
Maria Thomsen, Eva Skovlund, Halfdan Sorbye, et al.
Journal of the American Heart Association
|
March 3, 2020
Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease
Jakob Schroder, Janus Christian Jakobsen, Per Winkel, et al.
Page
of 60